Citi Pharma Limited (PSX:CPHL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
76.05
+0.32 (0.42%)
At close: Mar 11, 2026
Market Cap17.37B -25.6%
Revenue (ttm)14.10B +6.9%
Net Income1.04B +26.7%
EPS4.55 +26.4%
Shares Out228.46M
PE Ratio16.72
Forward PE18.11
Dividend3.50 (4.62%)
Ex-Dividend DateOct 17, 2025
Volume861,347
Average Volume1,981,072
Open75.89
Previous Close75.73
Day's Range75.25 - 78.40
52-Week Range60.50 - 105.31
Beta0.42
RSI41.58
Earnings DateFeb 13, 2026

About Citi Pharma

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Its product portfolio includes capsules, tablet, syrup drops, ointment, sachet, and formulation. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan. [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 2012
Employees 531
Stock Exchange Pakistan Stock Exchange
Ticker Symbol CPHL
Full Company Profile

Financial Performance

In fiscal year 2025, Citi Pharma's revenue was 13.15 billion, an increase of 6.00% compared to the previous year's 12.41 billion. Earnings were 892.04 million, an increase of 7.03%.

Financial Statements